# Mina Fahim

> Mina Fahim is the CEO and President of MediView XR, a Cleveland-based medical technology company giving clinicians a form of 3D 'X-ray vision' by fusing CT scans and live ultrasound into holograms surgeons can see through a headset. A University of Minnesota-trained biomedical engineer and former Medtronic research engineer, he helped steer MediView to the first FDA 510(k) clearance for an AR device that combines live imaging with 3D XR visualization (the XR90), a $24M Series A led by GE HealthCare, and the world's first-in-human AR tumor ablation at the Cleveland Clinic. His mantra: simplify, democratize, and inform care.

- **Role:** CEO & President at MediView XR, Inc.
- **Organizations:** MediView XR, Inc., Medtronic, Abbott, Beckman Coulter, Excelen
- **Nationality:** American
- **Education:** B.S., Biomedical/Medical Engineering, University of Minnesota-Twin Cities, M.S., Management of Technology, University of Minnesota-Twin Cities
- **Known for:** Led MediView to the first FDA 510(k) clearance for an AR device combining live imaging with 3D XR visualization (XR90)., Closed a $24M Series A led by GE HealthCare with Cleveland Clinic, Mayo Clinic, Edge Ventures and JobsOhio Growth Capital Fund., Oversaw the platform used in the world's first-in-human augmented reality tumor ablation at the Cleveland Clinic.

## Career timeline

- **2010** — Earns B.S. in Biomedical Engineering from the University of Minnesota.
- **2014** — Completes M.S. in Management of Technology at the University of Minnesota while building a medical-device career.
- **pre-2019** — Holds engineering and leadership roles at Medtronic (Principal Research Development Engineer), Abbott, Beckman Coulter, and Excelen.
- **2019** — Joins MediView XR, rising through CTO and President & CTO to CEO & President.
- **2022** — MediView raises $9.9M to advance its AR surgical navigation platform.
- **2023** — MediView earns the first FDA 510(k) clearance for an AR device combining live imaging with 3D XR visualization - the XR90 (July 20, 2023).
- **2025** — Closes a $24M Series A led by GE HealthCare with Cleveland Clinic, Mayo Clinic, Edge Ventures and JobsOhio; launches multicenter XR90 biopsy study.

## Achievements

- Led MediView to the first FDA 510(k) clearance for an AR device combining live imaging with 3D XR visualization (XR90).
- Closed a $24M Series A led by GE HealthCare with Cleveland Clinic, Mayo Clinic, Edge Ventures and JobsOhio Growth Capital Fund.
- Oversaw the platform used in the world's first-in-human augmented reality tumor ablation at the Cleveland Clinic.
- Built strategic partnerships with Microsoft (HoloLens 2), GE HealthCare and the Cleveland Clinic.
- Launched a multicenter study validating XR90 surgical navigation for soft-tissue biopsy across leading US hospitals.

## Latest updates

- **2025-10** — MediView closed a $24M Series A led by GE HealthCare to scale XR90 surgical navigation and AR medical imaging.
- **2025-07** — MediView launched a multicenter study validating XR90 surgical navigation for soft-tissue biopsy.

## Links

- Website: https://mediview.com
- LinkedIn: http://www.linkedin.com/in/mina-fahim-59b1776a
- Twitter/X: https://twitter.com/MinaSFahim
- Facebook: https://facebook.com/MediViewXR/

---

Profile page: https://yespress.io/mina-fahim
Published by YesPress — https://yespress.io
Last updated: 2026-07-01